FR2332M - - Google Patents
Download PDFInfo
- Publication number
- FR2332M FR2332M FR920727A FR920727A FR2332M FR 2332 M FR2332 M FR 2332M FR 920727 A FR920727 A FR 920727A FR 920727 A FR920727 A FR 920727A FR 2332 M FR2332 M FR 2332M
- Authority
- FR
- France
- Prior art keywords
- acetamido
- caproic acid
- administration
- active principle
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003814 drug Substances 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 230000003266 anti-allergic effect Effects 0.000 description 5
- 230000002804 anti-anaphylactic effect Effects 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 239000000829 suppository Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 2
- QISSLHPKTCLLDL-UHFFFAOYSA-N N-Acetylcaprolactam Chemical compound CC(=O)N1CCCCCC1=O QISSLHPKTCLLDL-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000011200 topical administration Methods 0.000 description 2
- ASTAFWNFKJWCLV-UHFFFAOYSA-N 3-acetylazepan-2-one Chemical compound CC(=O)C1CCCCNC1=O ASTAFWNFKJWCLV-UHFFFAOYSA-N 0.000 description 1
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000007665 chronic toxicity Effects 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229960003699 evans blue Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR920727A FR2332M (d) | 1963-01-08 | 1963-01-08 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR920727A FR2332M (d) | 1963-01-08 | 1963-01-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR2332M true FR2332M (d) | 1964-03-13 |
Family
ID=8583702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR920727A Expired FR2332M (d) | 1963-01-08 | 1963-01-08 |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2332M (d) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2901914A1 (de) * | 1978-01-30 | 1979-08-02 | Vinas Lab | Neues derivat der n-acetyl-amino-6- capronsaeure, verfahren zu dessen herstellung und arzneimittel unter verwendung des derivats als wirkstoff |
| EP0214357A1 (en) * | 1985-09-05 | 1987-03-18 | CHINOIN S.p.A. | Novel chemical compound having antimycotic, cicatrizing and antiinflammatory activity |
-
1963
- 1963-01-08 FR FR920727A patent/FR2332M/fr not_active Expired
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2901914A1 (de) * | 1978-01-30 | 1979-08-02 | Vinas Lab | Neues derivat der n-acetyl-amino-6- capronsaeure, verfahren zu dessen herstellung und arzneimittel unter verwendung des derivats als wirkstoff |
| EP0214357A1 (en) * | 1985-09-05 | 1987-03-18 | CHINOIN S.p.A. | Novel chemical compound having antimycotic, cicatrizing and antiinflammatory activity |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0261017B1 (fr) | Esters d'aminoacides d'alcools cycloaliphatiques, procédé de préparation et utilisation comme médicaments | |
| FR2332M (d) | ||
| CH561183A5 (d) | ||
| US3812109A (en) | Substituted indenyl glucoronide esters | |
| CA2112866C (fr) | Nouveaux derives 2-cyano 3-hydroxy propenamides, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant | |
| EP0200605A1 (fr) | Dérivés de nitrofuranne, leur préparation et leur application en thérapeutique | |
| FR2532647A1 (fr) | Thioesters d'acide acetylsalicylique, procede pour les preparer et compositions pharmaceutiques qui en renferment | |
| CA1097684A (fr) | PROCEDE DE PREPARATION D'ACIDES.gamma.ARYL .gamma.OXO ISOVALERIQUES | |
| US4091097A (en) | Treatment of elevated histamine and uric acid levels | |
| EP0077720A1 (fr) | Dérivés de biphényl alcoyl carboxylates, leur procédé de préparation et leur utilisation comme médicaments | |
| DE1795543C3 (de) | Indolyl-(3)-alkancarbonsaure-niedrig alkylester | |
| US4024253A (en) | Treatment of elevated histamine and uric acid levels | |
| EP0020230B1 (fr) | Acides p-biphényl-4 méthyl-2 buten-3 oiques, procédé pour leur préparation, compositions pharmaceutiques les contenant et leur utilisation | |
| EP0047207B1 (fr) | N-(1-allyl 2-pyrrolidinyl méthyl) 2-méthoxy 4-amino 5-méthylsulfamoyl benzamide, son procédé de préparation et son application comme médicament | |
| DE3409415A1 (de) | Arzneimittel, insbesondere gegen entzuendungen | |
| CH529153A (fr) | Procédé de préparation de pyrazolo (1,2-b) phtalazine-1,5 (10H)-diones | |
| LUTZ et al. | ANTIMALARIALS. 1 AMIDES RELATED TO PHENYLPANTOTHENONE | |
| BE897217A (fr) | NOUVEAU MEDICAMENT ANTI-INFLAMMATOIRE, ANALGESIQUE ET ANTIPYRETIQUE A BASE DE (P-CHLOROBENZOYL-1, METHYL- 2- Methoxy-5) Indole-3 Acetate de P-Acetamidophenol | |
| FR1840M (d) | ||
| EP0653415B1 (de) | (Aryl-[1'(aryl)-alkyl]-methyliden)- bzw. (Aryl-[1'-(aryl)-alkyl]-methyl)-dicarbonsäure-alkylester bzw. ihre Thiocarbonsäureesteranaloga, Verfahren zu deren Herstellung und ihre Verwendung | |
| US4435591A (en) | Compound with analgesic, antiinflammatory and antipyretic activity, and pharmaceutical compositions therefrom | |
| BE734479A (d) | ||
| EP0024616B1 (de) | 1-(3'-Acyloxyphenyl)-2-aminoethanole, deren Säureadditionssalze, diese enthaltende Arzneimittel, sowie Verfahren zu ihrer Herstellung | |
| EP0080609B1 (en) | Novel compound having analgesic, antiinflammatory and antipyretic activity, process for its preparation and pharmaceutical compositions containing it | |
| FR64F (fr) | Nouveau médicament doué notamment d'activité antimitotique. |